Company page

Theravance Biopharma, Inc.

Theravance Biopharma, Inc. (Ticker: TBPH) is a public company based in the United States with a market capitalization of approximately $854.7 million. The company focuses on developing innovative therapeutics to address unmet medical needs. Theravance is committed to advancing its pipeline of product candidates aimed at improving patient outcomes.